Rezolute, Inc. Common Stock (NV) (RZLT) is a publicly traded Healthcare sector company. As of November 13, 2026, RZLT trades at $4.48 with a market cap of $393.69M and a P/E ratio of -5.34. RZLT moved +15.79% today. Year to date, RZLT is +97.15%; over the trailing twelve months it is -61.26%. Its 52-week range spans $1.07 to $11.46. Analyst consensus is strong buy with an average price target of $10.43. Rallies surfaces RZLT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks RZLT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $4.48 |
| Market Cap | $393.69M |
| P/E Ratio | -5.34 |
| EPS | $-0.75 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.46 |
| 52-Week Low | $1.07 |
| Volume | 282.83K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-77.59M |
| Gross Margin | 0.00% |
8 analysts cover RZLT: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.43.